US Patent Family Members and Approved Drugs for South Korea Patent: 20010031224
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for South Korea Patent: KR20010031224
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 6,004,297 | 2018-01-30 | insulin aspart | Novo Nordisk Inc. | NOVOLOG |
| 6,004,297 | 2018-01-30 | insulin aspart protamine and insulin aspart | Novo Nordisk Inc. | NOVOLOG MIX 70/30 |
| 6,004,297 | 2018-01-30 | insulin aspart protamine and insulin aspart | Novo Nordisk Inc. | NOVOLOG MIX 50/50 |
| 6,004,297 | 2018-01-30 | somatropin | Novo Nordisk Inc. | NORDITROPIN |
| 6,004,297 | 2018-01-30 | insulin detemir | Novo Nordisk Inc. | LEVEMIR |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
